BeStock  
Stocks › Biotechnology › TRAX

First Tracks Biotherapeutics TRAX

US equityMarket cap rank #2772Biotechnology
$41.64 −$2.82 (-6.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $40.70 -2.26%
Open$43.99
Prev close$44.46
Day range$41.23 – $44.74
Volume504.4K
Market cap$1.75B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-11.3x
CheapRich

Near the bottom of its 5-year range · 5th percentile, 5-year average -7.0x

Price / book13.1x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average 6.1x

#5041 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-14x-9x-4x1xApr '26Aug '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$44.71
Price vs. fair value-6.9%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 13.11 – 6.09 96% (pricier than usual) #5041 of 5329 (1 = cheapest)
PE -11.29 -14.44 -6.97 5% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on TRAX.

Sign in to join the discussion.

Scroll to Top